Position in PTCT
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$92,279,291
-$33,698,925 QoQ
Shares Held
1,354,459
-18.3% QoQ
Ownership
16.3%
of shares outstanding
% of Portfolio
1.44%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
10 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Derivatives in PTCT
reported options exposure · as of Dec 31, 2023CallValue
$369,304
CallShares
13,400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Jefferies Financial Group Inc. holds $507,365,833 across 84 Biotechnology names. PTCT ranks #1 (18.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTCT |
Ptc Therapeutics, Inc.
This page
|
1,354,459 | $92,279,291 | |
| 2 | IMTX |
Immatics N.V.
|
5,059,551 | $49,785,981 | |
| 3 | URGN |
UroGen Pharma Ltd.
|
2,199,652 | $39,549,742 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
175,599 | $33,196,990 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
468,146 | $26,445,567 | |
| 6 | IMNM |
Immunome Inc.
|
1,160,715 | $25,384,837 | |
| 7 | ARGX |
Argenx SE
|
30,005 | $21,911,151 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
202,410 | $16,986,247 |
All Filings in PTCT
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $92,279,291 | 1,354,459 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $125,978,216 | 1,658,481 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $97,251,688 | 1,584,678 | Shares | Defined | 2025-11-13 | |
| 2024-09-30 | $19,399,404 | 522,895 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $15,990,129 | 522,895 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $7,938,515 | 272,895 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $7,631,226 | 276,895 | Shares | Defined | 2024-05-06 | |
| 2023-12-31 | $369,304 | 13,400 | Call | Defined | 2024-05-06 | |
| 2023-09-30 | $672,300 | 30,000 | Call | Defined | 2023-11-14 | |
| 2023-09-30 | $6,008,905 | 268,135 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $10,895,289 | 267,895 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $765,352 | 15,800 | Shares | Defined | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||